Ads
related to: celgene merger- Careers
Join our Mission to Improve
the Lives of Patients.
- Pipeline
Review our Pipeline and
See How We're Changing Treatment.
- Approved Medicines
See the Approved Treatments
Using Our Antibody Science.
- Sign Up
Sign Up for Updates, News
and Much More.
- Antibody Science
Explore Our Unique Platforms
For Creating Antibody Treatments.
- About Us
Discover the Unique Approach
That Makes Genmab Different.
- Careers
Search results
Bristol Myers must face $6.4 billion lawsuit over delayed cancer drug
Reuters via Yahoo Finance· 2 years agoA U.S. judge on Friday refused to dismiss a $6.4 billion lawsuit accusing Bristol Myers Squibb Co of...
New York Judge Denies Bristol Myers Claim To Dismiss Lawsuit Over Delayed Cancer Drug Approval:...
Benzinga via Yahoo Finance· 2 years agoAccording to a Reuters report, U.S. District Judge Jesse Furman in Manhattan refused to dismiss a...
Bear of the Day: Ligand Pharmaceuticals (LGND)
Zacks via Yahoo Finance· 11 months agoLigand Pharmaceuticals (LGND) is a $1 billion operator of bio-pharmaceutical acquisitions and development. The San Diego company focuses on developing or...
Pfizer is buying a cancer biotech in one of the biggest pharma deals in history
Quartz via Yahoo Finance· 1 year agoPharmaceutical giant Pfizer is buying Seagen, a biotech company making a novel type of cancer...
Former Bristol Myers CEO tapped as Novartis’ next board chair
BioPharma Dive via Yahoo Finance· 1 month agoGiovanni Caforio, who left Bristol Myers in November after eight years as CEO, is set to succeed...
Amgen (AMGN) Wins Patent Appeal for Blockbuster Psoriasis Drug
Zacks via Yahoo Finance· 1 year agoThe Appeal Court's decision upholding the patents for Amgen's (AMGN) blockbuster psoriasis drug...
Is Bristol Myers Squibb a Top Dividend Stock?
Motley Fool· 1 year agoBristol Myers Squibb (BMS) (NYSE: BMY), a multinational pharmaceutical company, has all the hallmarks of a top-shelf dividend stock. The company has...
Fresh Blood: 3 Stocks Ready to Rally Under New CEOs
InvestorPlace via Yahoo Finance· 11 months agoIn recent years, S&P 500 companies with new chief executive officers (CEOs) have become a regular occurrence. That’s because CEOs are moving on more...
3 Stocks to Snag for Less Than Book Value
InvestorPlace via Yahoo Finance· 11 months agoThe move to share repurchases over the last few years has made the price-to-book ratio less reliable for finding hidden opportunities in stocks. How’s...
Biotech landlord Alexandria on research clusters and the sector’s recovery
BioPharma Dive via Yahoo Finance· 2 months agoJoel Marcus, the longtime head of Alexandria Real Estate Equities, sees few near-term challengers to...